Research Papers

25 of 332 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis.
Roemer J; Klein A; Horneff G.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic…
Benny L; Mehta P; Ahmed S; Paul A; Sukumaran A; Mohanan M; Vijayan A; Kaveri K; Padmaja R; Shenoy P.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune …
Naveen R; Thakare DR; Kuwana M; Pauling JD; Day J; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; COVAD Study Group; Aggarwal R; Gupta L; Agarwal V; Makol A.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Long COVID in autoimmune rheumatic diseases.
Fedorchenko Y; Zimba O.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Unauthorized change of immunosuppressants by patients with rheumatic diseases in the COVID-19 pandemic: a cross-section…
Dahm S; Henes JC; Saur SJ.
Rheumatol Int (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis.
Sariyildiz A; Coskun Benlidayi I; Turk I; Zengin Acemoglu SS; Unal I.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREM…
Samanta J; Naidu G; Chattopadhyay A; Basnet A; Narang T; Dhir V; Dogra S; Jain S; Sharma A.
Rheumatol Int (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational study.
Berger SG; Witczak BN; Reiseter S; Schwartz T; Andersson H; Hetlevik SO; Berntsen KS; Sanner H; Lilleby V; Gunnarsson R; Molberg Ø; Sjaastad I; Stokke MK.
Rheumatol Int (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from referen…
Łosińska K; Korkosz M; Pripp AH; Haugeberg G.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Takayasu arteritis associated with autoimmune/inflammatory syndrome induced by adjuvants: a case-based review.
Simeonova D; Georgiev T; Shivacheva T.
Rheumatol Int (Unknown)
Published: 2023
2/6 Transparent
Burnout in South Asian rheumatologists in the COVID-19 pandemic: an online survey.
Khursheed T; Sharif M; Khan MS; Masood A; Aziz W; Shah S; Gupta L; Miraj MA.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association between levels of serotonin, melatonin, cortisol and the clinical condition of patients with rheumatoid art…
Wróbel A; Szklarczyk J; Barańska I; Majda A; Jaworek J.
Rheumatol Int (Unknown)
Published: 2023
1/6 Transparent
The biopsychosocial impact of hypermobility spectrum disorders in adults: a scoping review.
Clark NL; Johnson M; Rangan A; Kottam L; Swainston K.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
Felis-Giemza A; Chmurzyńska K; Kołodziejczyk B; Gazda A.
Rheumatol Int (Unknown)
Published: 2023
2/6 Transparent
Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the …
Sfikakis PP; Vassilopoulos D; Katsifis G; Vosvotekas G; Dimitroulas T; Sidiropoulos P; Vounotrypidis P; Bogdanos DP; Georgountzos AΙ; Bounas AG; Georgiou P; Gazi S; Kataxaki E; Liossis SN; Theodorou E; Papagoras C; Theotikos E; Vlachoyiannopoulos P; Voulgari PV; Kekki A; Antonakopoulos N; Boumpas DT.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis.
Charles-Schoeman C; Wang J; Shahbazian A; Wilhalme H; Brook J; Kaeley GS; Oganesian B; Ben-Artzi A; Elashoff DA; Ranganath VK.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Patient-reported outcomes in ANCA-associated vasculitis: a cross-sectional study to explore the interactions between pa…
Hurtado-Arias JJ; Ramírez-Mulhern I; Gonzalez-Martínez C; Merayo-Chalico J; Barrera-Vargas A; Hinojosa-Azaola A.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered ve…
Koster F; Bakx PLH; Kok MR; Barreto DL; Weel-Koenders AEAM.
Rheumatol Int (Unknown)
Published: 2023
2/6 Transparent
Polyangiitis overlap syndrome: a rare clinical entity.
Bruno L; Mandarano M; Bellezza G; Sidoni A; Gerli R; Bartoloni E; Perricone C.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: …
Wiegel J; Seppen BF; Nurmohamed MT; Ter Wee MM; Bos WH.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analyzing web searches for axial spondyloarthritis in Germany: a novel approach to exploring interests and unmet needs.
Berr K; Tizek L; Schielein MC; Welcker M; Knitza J; Kleinert S; Zink A.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inf…
Seppen BF; Wiegel J; Nurmohamed MT; Bos WH; Ter Wee MM.
Rheumatol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity.
Menon AR; Cherian S; Paul A; Kumar K; Ahmed S; Mehta P; Musthafa S; Gayathri B; Benny L; Shenoy P.
Rheumatol Int (Unknown)
Published: 2022
2/6 Transparent
Secondary immune-mediated thrombotic thrombocytopenic purpura in idiopathic inflammatory myopathy: a case-based review.
Ruffer N; Holzer MT; Bal LC; Melderis S; Krusche M; Huber TB; Kötter I.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient survey.
Labinsky H; Gupta L; Raimondo MG; Schett G; Knitza J.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared